Skip to content
Kalpvruksh Markets
Offline Log in

CONCORDBIONSEOffline

CONCORD BIOTECH · INE338H01029 · Small Cap · #503
672.70+17.20 (+2.62%)last close · 05 Nov 2026
Prev close
655.50
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹12,381 cr
52-week range · to 05 Nov 2026507.4793.75

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

CONCORDBIO is 15% below its 52-week high, above its 200-day average, behind Healthcare by 3.7 pts over 3 months — a Small Cap company, #503 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 200-day averages · below its 50-day average · 15% below its 52-week high
  • behind its industry by 3.7 pts over 3 months · rank 30 of 44 in Healthcare · −0.7% vs Nifty 500
  • traded value 1.8× usual · delivery 33% vs 45% usual
  • FPI −0.3 pp · DII +1.6 pp · MF schemes in Sept 2026: 15 bought, 28 cut · no promoter pledge · quarter ended 2026-09-30
  • Sept 2026 quarter: profit +11% year on year · revenue +25%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹12,381 cr
Rank
#503
Cap band
Small Cap
Nearest cut-off — Mid / Small
−63.79% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.9×
median 59,876
Delivered
1,12,247
Of volume
28%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+9.3%+3.3 pts—
1 month−1.7%−6.0 pts−5.4 pts
3 months−2.9%−0.7 pts−3.7 pts
6 months+10.1%+9.7 pts−0.7 pts
1 year−7.5%−5.0 pts—

Industry: Healthcare (Nifty 500 classification) · rank 30 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+3.4%
above
vs 50-day average
−3.6%
below
vs 200-day average
+6.2%
above
ATR (14)
5.4%
typical daily range
Volatility
60%
1 month, annualised
Beta
1.08
vs Nifty 500, 1 year
Traded value
1.8×
vs usual
Delivery
33%
usual 45%
From the 52-week high
−15.3%
place in range 58% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters44.1%44.1%44.1%44.1%
FPI7.6%7.8% +0.27.5% −0.37.3% −0.3
Mutual funds4.4%4.3% −0.14.4% +0.15.8% +1.4
Other DII5.1%4.9% −0.25.0% +0.15.1% +0.1
Individuals8.1%8.1%8.2% +0.18.8% +0.6
Others30.7%30.8% +0.230.8%28.9% −1.9

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
88,365
Individuals
83,138

Indian passive funds’ stake

2026-06-30

Of free float
0.34%
Of all shares
0.19%
Schemes
43
Days to unwind
1.0
at 100% of volume

1,99,818 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
61
43 index · 18 active
Bought more
37
Sold some
8
FundSharesChangeDid
Quant Healthcare Fund-Reg(G)Active+1,86,467+223.4%bought
Baroda BNP Paribas Health and Wellness Fund-Reg(G)Active+25,000+50.0%bought
Baroda BNP Paribas Innovation Fund-Reg(G)Active+17,929+28.9%bought
Invesco India Aggressive Hybrid Fund-Reg(G)Active−12,148−28.8%sold
HDFC NIFTY Smallcap 250 ETFIndex−278−0.7%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 2651114253−6.9%₹716 cr
Aug 265363344+47.4%₹810 cr
Jul 265102681−0.3%₹540 cr
Jun 2652425130+12.3%₹488 cr
May 2648416132−0.8%₹357 cr
Apr 264623043−11.9%₹391 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 1 of 11 disclosures
0 selected
04 Jun 2024Ravi KapoorDirectorSell10,000₹00.20%Gift

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    28 Oct 2026
  • Board outcome
    Outcome of Board Meeting-XBRL CONCORD BIOTECH LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 23-Sep-2026 for Bonus Shares
    24 Sept 2026
  • Board outcome
    Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    03 Aug 2026
  • Scheme / acquisition
    Concord Biotech Limited has informed the Exchange about Acquisition
    22 Jun 2026
  • Board outcome
    Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
    01 Jun 2026
  • Board outcome
    Outcome of Board Meeting-XBRL CONCORD BIOTECH LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 29-May-2026 for Dividend
    01 Jun 2026

CONCORDBIO: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
RecentBonus1:1—04 Nov 202604 Nov 2026
EarlierDividend₹7.55Final24 Jul 202624 Jul 2026
EarlierDividend₹10.7Final03 Sept 202503 Sept 2025
EarlierDividend₹8.75Final21 Jun 202422 Jun 2024

4 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.